Renaissance Technologies
GRTX

Renaissance Technologies’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History

Renaissance Technologies’s Portfolio GRTX Stock Details GRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-313,500
Closed -$46K – 4183
2023
Q4 		$46K Buy
+313,500
New +$48.7K ﹤0.01% 3471
2023
Q3 		– Sell
-217,900
Closed -$680K – 4227
2023
Q2 		$680K Buy
217,900
+14,400
+7% +$42.8K ﹤0.01% 2708
2023
Q1 		$521K Buy
203,500
+161,000
+379% +$332K ﹤0.01% 2866
2022
Q4 		$63K Sell
42,500
-115,268
-73% -$187K ﹤0.01% 3750
2022
Q3 		$275K Sell
157,768
-84,584
-35% -$120K ﹤0.01% 3252
2022
Q2 		$315K Sell
242,352
-196,782
-45% -$337K ﹤0.01% 3428
2022
Q1 		$1.04M Buy
+439,134
New +$1.14M ﹤0.01% 2700
2021
Q4 		– Sell
-23,670
Closed -$192K – 4302
2021
Q3 		$192K Sell
23,670
-500
-2% -$4.29K ﹤0.01% 3217
2021
Q2 		$238K Sell
24,170
-12,911
-35% -$105K ﹤0.01% 3216
2021
Q1 		$327K Buy
37,081
+16,311
+79% +$179K ﹤0.01% 3035
2020
Q4 		$212K Buy
20,770
+7,700
+59% +$84.2K ﹤0.01% 3116
2020
Q3 		$118K Sell
13,070
-8,993
-41% -$71.2K ﹤0.01% 3194
2020
Q2 		$158K Buy
+22,063
New +$234K ﹤0.01% 3203

Other funds holding GRTX

GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AI
Atom Investors Austin, Texas $1.4B AUM 23.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Renaissance Technologies's GRTX Position: Q1 2024 in Review

Renaissance Technologies sold out of Galera Therapeutics, Inc. Common Stock (GRTX) in Q1 2024, closing a stake of 313,500 shares — an estimated $46K sold.

Renaissance Technologies first reported a position in GRTX in Q2 2020 and held it in 13 quarters. The position peaked at $1.04M in Q1 2022. 36 funds tracked by Wall St. Rank hold GRTX as of Q1 2024.

  • Renaissance Technologies reported no remaining Galera Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Renaissance Technologies sold 313,500 Galera Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $46K.
  • Renaissance Technologies first reported a position in Galera Therapeutics, Inc. Common Stock in Q2 2020 and held it in 13 quarters.
  • Renaissance Technologies's Galera Therapeutics, Inc. Common Stock position peaked at $1.04M in Q1 2022.
  • 36 funds tracked by Wall St. Rank held Galera Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Renaissance Technologies's 13F filing for Q1 2024, filed 13 May 2024.